Search Results

Leveraging multi-omics data to empower quantitative systems pharmacology in immuno-oncology.

• Authors : Arulraj T; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.; Wang H

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Neoplasms*/Neoplasms*/Neoplasms*/genetics ; Pharmacology*

• Source: Briefings in bioinformatics [Brief Bioinform] 2024 Mar 27; Vol. 25 (3).Publisher: Oxford University Press Country of Publication: England NLM ID: 100912837 Publication Model: Print Cited Medium: Internet ISSN:

Record details

From Cold to Hot: Changing Perceptions and Future Opportunities for Quantitative Systems Pharmacology Modeling in Cancer Immunotherapy.

• Authors : Lemaire V; Genentech Inc., South San Francisco, California, USA.; Bassen D

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Pharmacology*; Humans

• Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2023 May; Vol. 113 (5), pp. 963-972. Date of Electronic Publication: 2022 Nov 10.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535

Record details

Simulations of tumor growth and response to immunotherapy by coupling a spatial agent-based model with a whole-patient quantitative systems pharmacology model.

• Authors : Ruiz-Martinez A; Department of Biomedical Engineering, Johns Hopkins, University School of Medicine, Baltimore, Maryland, United States of America.; Gong C

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/therapy ; Pharmacology*/Pharmacology*/Pharmacology*/methods; Combined Modality Therapy

• Source: PLoS computational biology [PLoS Comput Biol] 2022 Jul 22; Vol. 18 (7), pp. e1010254. Date of Electronic Publication: 2022 Jul 22 (Print Publication: 2022).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238922 Publication Model: eCollection Cited Medium: Internet

Record details

Pharmacology Focus: Vaccination Considerations for Patients with Cancer.

• Authors : LaPorte K; College of Pharmacy and Allied Health Professions, South Dakota State University.; Avera Cancer Institute, Sioux Falls, South Dakota.

Subjects: Neoplasms* ; Pharmacology*; Humans

• Source: South Dakota medicine : the journal of the South Dakota State Medical Association [S D Med] 2021 Oct; Vol. 74 (10), pp. 490-491.Publisher: South Dakota State Medical Association Country of Publication: United States NLM ID: 101265265 Publication Model: Print Cited Medium: Print

Record details

Advances in the molecular pharmacology of bone and cancer-related bone diseases.

• Authors : Edwards CM; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.

Subjects: Bone Diseases*/Bone Diseases*/Bone Diseases*/drug therapy ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Pharmacology*

• Source: British journal of pharmacology [Br J Pharmacol] 2021 May; Vol. 178 (9), pp. 1889-1890.Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print Cited Medium: Internet ISSN: 1476-5381 (Electronic)

Record details

Mechanism of action of celastrol against rheumatoid arthritis: A network pharmacology analysis.

• Authors : Song X; Department of Biological Sciences, Xinyang Normal University, Xinyang 464000, China; Institute for Conservation and Utilization of Agro-bioresources in Dabie Mountains, Xinyang 464000, China. Electronic address: .

Subjects: Computational Biology* ; Pharmacology*; Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*drug therapy

• Source: International immunopharmacology [Int Immunopharmacol] 2019 Sep; Vol. 74, pp. 105725. Date of Electronic Publication: 2019 Jul 02.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

QSP-IO: A Quantitative Systems Pharmacology Toolbox for Mechanistic Multiscale Modeling for Immuno-Oncology Applications.

• Authors : Sové RJ; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Jafarnejad M

Subjects: Immune Checkpoint Proteins/Immune Checkpoint Proteins/Immune Checkpoint Proteins/*pharmacology ; Immunotherapy/Immunotherapy/Immunotherapy/*adverse effects ; Neoplasms/Neoplasms/Neoplasms/*drug therapy

• Source: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2020 Sep; Vol. 9 (9), pp. 484-497. Date of Electronic Publication: Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Systems Biology, Systems Medicine, Systems Pharmacology: The What and The Why.

• Authors : Stéphanou A; Université Grenoble Alpes, CNRS, TIMC-IMAG/DyCTIM2, 38000, Grenoble, France. .; Fanchon E

Subjects: Pharmacology* ; Precision Medicine* ; Systems Analysis*

• Source: Acta biotheoretica [Acta Biotheor] 2018 Dec; Vol. 66 (4), pp. 345-365. Date of Electronic Publication: 2018 May 09.Publisher: Springer Country of Publication: Netherlands NLM ID: 0421520 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Agricola

Record details

Agricola

Record details